Pleasanton, CA, United States of America

Yan Lou

This inventor holds 74 USPTO granted patents and 21 published patent applications, plus 3 CIPO patents and 36 EPO patents, primarily in Pharmaceutical Compounds (CPC class C07D). Top assignees: Roche Palo Alto LLC, Hoffmann-La Roche Inc., Nikang Therapeutics, Inc.. Active years: 2009-2025.

USPTO Granted Patents = 74 (Patent Applications = 21)

% Patents Active = 48.6

CIPO Patents = 3 (Patent Applications = 4)

EPO Patents = 36 (Patent Applications = 57)

Average Co-Inventor Count = 3.9

ph-index = 11

Forward Citations = 484(Granted Patents)

Forward Citations (Not Self Cited) = 414(Dec 10, 2025)

Inventors with similar research interests:

Location History:

San Jose, CA (US) (2009 - 2013)
Clifton, NJ (US) (2012 - 2013)
Glen Ridge, NJ (US) (2013 - 2014)
Fremont, CA (US) (2014 - 2016)
Pleasonton, CA (US) (2019)
Wilmington, DE (US) (2022)
Pleasanton, CA (US) (2015 - 2024)
Dallas, TX (US) (2023 - 2024)

Company Filing History:

Hoffmann-La Roche Inc.

patents

15 out of 15

Nikang Therapeutics, Inc.

patents

4. 11 out of 20

Newave Pharmaceutical Inc.

Principia Biopharma Inc.

patents

7. 2 out of 14

Chugai Pharmaceutical Co.

patents

8. 1 out of 180

F. Hoffmann-La Roche Ag

patents

where one patent can have more than one assignee

Years Active: 2009-2025

Loading Chart...

Areas of Expertise:

BCL-2 Inhibitors

Kinase Inhibitors

Hypoxia Inducible Factor

Immunoproteasome

Tricyclic Derivatives

Heterocyclic Derivatives

Covalent Inhibitors

Therapeutic Agents

SRC Homology-2

Bruton's Tyrosine Kinase

Neoplastic Diseases

Tetrahydro Compounds

74 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12435034 - Process of preparing 3-fluoro-5(((1R,2AR)-3,3,4,4-tetrafluoro-1,2A-dihydroxy-2,2A,3,4-tetrahydro-1H-cyclopenta[cd]inden-7-yl)-oxy)benzonitrile (2025-10-07),

2. 12415779 - Processes of making 3-fluoro-5-(((1S,2aR)-1,3,3,4,4-pentafluoro-2a-hydroxy-2,2a,3,4-tetrahydro-1H-cyclopenta[cd]inden-7-yl)oxy)-benzonitrile and polymorphs thereof (2025-09-16),

3. 12410190 - Condensed heterocyclic derivates as BCL-2 inhibitors for the treatment of neoplastic diseases (2025-09-09),

4. 12391642 - Tetrahydro-1H-cyclopenta[cd]indene derivatives as hypoxia inducible factor-2(alpha) inhibitors (2025-08-19),

5. 12331026 - Sulfonamido derivatives as cyclin-dependent kinase 2 inhibitors (2025-06-17),

6. 12312370 - Immunoproteasome inhibitors (2025-05-27),

7. 12264167 - Fused tricyclic ring derivatives as SRC homology-2 phosphate inhibitors (2025-04-01),

8. 12171741 - 2,3-dihydrobenzo[b]thiophene derivatives as hypoxia inducible factor-2(alpha) inhibitors (2024-12-24),

9. 12077506 - Indane derivatives as hypoxia inducible factor-2(α) inhibitors (2024-09-03),

10. 12024531 - Immunoproteasome inhibitors (2024-07-02),

11. 11993610 - BCL-2 inhibitors (2024-05-28),

12. 11827656 - Immunoproteasome inhibitors (2023-11-28),

13. 11753366 - Tetrahydro-1H-cyclopenta[cd]indene derivatives as hypoxia inducible factor-2(alpha) inhibitors (2023-09-12),

14. 11680072 - Condensed heterocyclic derivates as BCL-2 inhibitors for the treatment of neoplastic diseases (2023-06-20),

15. 11634382 - Process of preparing 3-fluoro-5(((1R,2aR)-3,3,4,4-tetrafluoro-1,2a-dihydroxy-2,2a,3,4-tetrahydro-1H-cyclopenta[cd]inden-7-yl)-oxy)benzonitrile (2023-04-25),

Title: Inventor Yan Lou - Pioneering Innovations in Pleasanton

Introduction: Yan Lou is a visionary inventor based in Pleasanton, CA, known for her groundbreaking contributions to various technological fields.

Latest Patents: Yan Lou holds several patents in the areas of artificial intelligence, renewable energy, and biotechnology, showcasing her diverse range of expertise.

Career Highlights: With over two decades of experience in research and development, Yan Lou has led numerous successful projects that have resulted in cutting-edge inventions with real-world applications.

Collaborations: Throughout her career, Yan Lou has collaborated with top research institutions, leading companies, and universities, fostering a culture of innovation and knowledge-sharing.

Conclusion: Yan Lou's passion for innovation and her relentless pursuit of excellence continue to inspire the next generation of inventors and shape the future of technology.